BACKGROUND AND PURPOSE: Endovascular treatment for acute ischemic stroke consists of various mechanical and pharmacologic modalities used for recanalization of arterial occlusions. We performed this study to determine the relationship among procedure time, recanalization, and clinical outcomes in patients with acute ischemic stroke undergoing endovascular treatment. MATERIALS AND METHODS: We analyzed data from consecutive patients with acute ischemic stroke who underwent endovascular treatment during a 6-year period. Demographic characteristics, NIHSS score before and 24 hours after the procedure, and discharge mRS score were ascertained. Procedure time was defined by the time interval between microcatheter placement and recanalization or completion of the procedure. We estimated the procedure time after which favorable clinical outcome was unlikely, even after adjustment for age, time from symptom onset, and admission NIHSS scores. RESULTS: We analyzed 209 patients undergoing endovascular treatment (mean age, 65 ± 16 years; 109 [52%] men; mean admission/preprocedural NIHSS score, 15.3 ± 6.8). Complete or partial recanalization was observed in 176 (84.2%) patients, while unfavorable outcome (mRS 3-6) was observed in 138 (66%) patients at discharge. In univariate analysis, patients with procedure time ≤30 minutes had lower rates of unfavorable outcome at discharge compared with patients with procedure time ≥30 minutes (52.3% versus 72.2%, P = .0049). In our analysis, the rates of favorable outcomes in endovascularly treated patients after 60 minutes were lower than rates observed with placebo treatment in the Prourokinase for Acute Ischemic Stroke Trial. In logistic regression analysis, unfavorable outcome was positively associated with age (P = .0012), admission NIHSS strata (P = .0017), and longer procedure times (P = .0379). CONCLUSIONS: Procedure time in patients with acute ischemic stroke appears to be a critical determinant of outcomes following endovascular treatment. This highlights the need for procedure time guidelines for patients being considered for endovascular treatment in acute ischemic stroke.
BACKGROUND AND PURPOSE: Endovascular treatment for acute ischemic stroke consists of various mechanical and pharmacologic modalities used for recanalization of arterial occlusions. We performed this study to determine the relationship among procedure time, recanalization, and clinical outcomes in patients with acute ischemic stroke undergoing endovascular treatment. MATERIALS AND METHODS: We analyzed data from consecutive patients with acute ischemic stroke who underwent endovascular treatment during a 6-year period. Demographic characteristics, NIHSS score before and 24 hours after the procedure, and discharge mRS score were ascertained. Procedure time was defined by the time interval between microcatheter placement and recanalization or completion of the procedure. We estimated the procedure time after which favorable clinical outcome was unlikely, even after adjustment for age, time from symptom onset, and admission NIHSS scores. RESULTS: We analyzed 209 patients undergoing endovascular treatment (mean age, 65 ± 16 years; 109 [52%] men; mean admission/preprocedural NIHSS score, 15.3 ± 6.8). Complete or partial recanalization was observed in 176 (84.2%) patients, while unfavorable outcome (mRS 3-6) was observed in 138 (66%) patients at discharge. In univariate analysis, patients with procedure time ≤30 minutes had lower rates of unfavorable outcome at discharge compared with patients with procedure time ≥30 minutes (52.3% versus 72.2%, P = .0049). In our analysis, the rates of favorable outcomes in endovascularly treated patients after 60 minutes were lower than rates observed with placebo treatment in the Prourokinase for Acute Ischemic Stroke Trial. In logistic regression analysis, unfavorable outcome was positively associated with age (P = .0012), admission NIHSS strata (P = .0017), and longer procedure times (P = .0379). CONCLUSIONS: Procedure time in patients with acute ischemic stroke appears to be a critical determinant of outcomes following endovascular treatment. This highlights the need for procedure time guidelines for patients being considered for endovascular treatment in acute ischemic stroke.
Authors: A I Qureshi; Z Ali; M F Suri; S H Kim; A A Shatla; A J Ringer; D K Lopes; L R Guterman; L N Hopkins Journal: Neurosurgery Date: 2001-07 Impact factor: 4.654
Authors: A I Qureshi; M F Suri; A A Shatla; A J Ringer; R D Fessler; Z Ali; L R Guterman; L N Hopkins Journal: Neurosurgery Date: 2000-08 Impact factor: 4.654
Authors: M J Alberts; G Hademenos; R E Latchaw; A Jagoda; J R Marler; M R Mayberg; R D Starke; H W Todd; K M Viste; M Girgus; T Shephard; M Emr; P Shwayder; M D Walker Journal: JAMA Date: 2000-06-21 Impact factor: 56.272
Authors: T C Burns; G J Rodriguez; S Patel; H M Hussein; A L Georgiadis; K Lakshminarayan; A I Qureshi Journal: AJNR Am J Neuroradiol Date: 2008-09-10 Impact factor: 3.825
Authors: Jefferson T Miley; Muhammad Zeeshan Memon; Haitham M Hussein; Douglas A Valenta; M Fareed K Suri; Gabriela Vazquez; Adnan I Qureshi Journal: J Neuroimaging Date: 2011-04 Impact factor: 2.486
Authors: Thanh N Nguyen; Viken L Babikian; Rafael Romero; Aleksandra Pikula; Carlos S Kase; Tudor G Jovin; Alexander M Norbash Journal: Front Neurol Date: 2011-03-08 Impact factor: 4.003
Authors: J A Knox; M D Alexander; D B McCoy; D C Murph; P J Hinckley; J C Ch'ang; C F Dowd; V V Halbach; R T Higashida; M R Amans; S W Hetts; D L Cooke Journal: AJNR Am J Neuroradiol Date: 2020-01-30 Impact factor: 3.825
Authors: Adnan I Qureshi; Mushtaq H Qureshi; Iryna Lobanova; Asif Bashir; Asif A Khan; Stephen M Bologna; Michelle Peterson; M Fareed K Suri Journal: J Vasc Interv Neurol Date: 2016-01
Authors: Adnan I Qureshi; Foad Abd-Allah; Aitziber Aleu; John J Connors; Ricardo A Hanel; Ameer E Hassan; Haitham M Hussein; Nazli A Janjua; Rakesh Khatri; Jawad F Kirmani; Mikael Mazighi; Heinrich P Mattle; Jefferson T Miley; Thanh N Nguyen; Gustavo J Rodriguez; Qaisar A Shah; Adnan H Siddiqui; Jose I Suarez; M Fareed K Suri; Reha Tolun Journal: J Vasc Interv Neurol Date: 2014-05
Authors: Adnan I Qureshi; Sarwat Gilani; Malik M Adil; Shahram Majidi; Ameer E Hassan; Jefferson T Miley; Gustavo J Rodriguez Journal: J Vasc Interv Neurol Date: 2014-06